MRI-guided transurethral ultrasound therapy enables full prostate gland coagulation: Investigations in gel phantoms

W. A. N'Djin, M. Burtnyk, X. Patel, M. Bronskill, R. Chopra

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

MRI-guided transurethral ultrasound therapy has previously been evaluated in human volunteers by treating a prostate subvolume, prior to radical prostatectomy. Extension of this technique to full clinical use requires validation of the technique for coagulating a volume of tissue equivalent to the entire gland. This in-vitro study evaluates approaches for treating the whole prostate gland by comparing various treatment strategies. An 8-element ultrasound therapy system was evaluated in gel phantoms using 6 human prostate profiles segmented from MR clinical images (average volume: 36 cm3). Real-time MR-thermometry feedback was performed over nine slices covering the entire prostate. Decisions on acoustic power, frequency, and device rotation rate were made based on prostate target radii and temperature maps updated every 7s. Low and high power treatment approaches (10, 20 W/cm2) were tested as well as single-and dual-frequency strategies (8.1, 4.6/14.4 MHz). Decreasing frequency to 4.6 MHz enabled treating 97% of the gland on average. A 20/10 W/cm2 dual-frequency 4.6/14.4 MHz treatment was the most efficient configuration in achieving full human prostate treatments. Treatments were performed more quickly (<30min) with enhanced treatment safety close to the base and apex. Transurethral thermal therapy has been validated in vitro for full gland treatment in human prostate geometries.

Original languageEnglish (US)
Title of host publicationAIP Conference Proceedings
Pages265-270
Number of pages6
Volume1481
DOIs
StatePublished - 2012
Event11th International Symposium on Therapeutic Ultrasound, ISTU 2011 - New York, NY, United States
Duration: Apr 11 2011Apr 13 2011

Other

Other11th International Symposium on Therapeutic Ultrasound, ISTU 2011
CountryUnited States
CityNew York, NY
Period4/11/114/13/11

Fingerprint

prostate gland
coagulation
therapy
gels
glands
temperature measurement
safety
apexes
coverings
radii
acoustics

Keywords

  • dualfrequency
  • MRT feedback control
  • Prostate cancer
  • transurethral ultrasound therapy

ASJC Scopus subject areas

  • Physics and Astronomy(all)

Cite this

N'Djin, W. A., Burtnyk, M., Patel, X., Bronskill, M., & Chopra, R. (2012). MRI-guided transurethral ultrasound therapy enables full prostate gland coagulation: Investigations in gel phantoms. In AIP Conference Proceedings (Vol. 1481, pp. 265-270) https://doi.org/10.1063/1.4757346

MRI-guided transurethral ultrasound therapy enables full prostate gland coagulation : Investigations in gel phantoms. / N'Djin, W. A.; Burtnyk, M.; Patel, X.; Bronskill, M.; Chopra, R.

AIP Conference Proceedings. Vol. 1481 2012. p. 265-270.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

N'Djin, WA, Burtnyk, M, Patel, X, Bronskill, M & Chopra, R 2012, MRI-guided transurethral ultrasound therapy enables full prostate gland coagulation: Investigations in gel phantoms. in AIP Conference Proceedings. vol. 1481, pp. 265-270, 11th International Symposium on Therapeutic Ultrasound, ISTU 2011, New York, NY, United States, 4/11/11. https://doi.org/10.1063/1.4757346
N'Djin, W. A. ; Burtnyk, M. ; Patel, X. ; Bronskill, M. ; Chopra, R. / MRI-guided transurethral ultrasound therapy enables full prostate gland coagulation : Investigations in gel phantoms. AIP Conference Proceedings. Vol. 1481 2012. pp. 265-270
@inproceedings{7f9e9b77eb4b4a90965e9f5f8d5c8fc0,
title = "MRI-guided transurethral ultrasound therapy enables full prostate gland coagulation: Investigations in gel phantoms",
abstract = "MRI-guided transurethral ultrasound therapy has previously been evaluated in human volunteers by treating a prostate subvolume, prior to radical prostatectomy. Extension of this technique to full clinical use requires validation of the technique for coagulating a volume of tissue equivalent to the entire gland. This in-vitro study evaluates approaches for treating the whole prostate gland by comparing various treatment strategies. An 8-element ultrasound therapy system was evaluated in gel phantoms using 6 human prostate profiles segmented from MR clinical images (average volume: 36 cm3). Real-time MR-thermometry feedback was performed over nine slices covering the entire prostate. Decisions on acoustic power, frequency, and device rotation rate were made based on prostate target radii and temperature maps updated every 7s. Low and high power treatment approaches (10, 20 W/cm2) were tested as well as single-and dual-frequency strategies (8.1, 4.6/14.4 MHz). Decreasing frequency to 4.6 MHz enabled treating 97{\%} of the gland on average. A 20/10 W/cm2 dual-frequency 4.6/14.4 MHz treatment was the most efficient configuration in achieving full human prostate treatments. Treatments were performed more quickly (<30min) with enhanced treatment safety close to the base and apex. Transurethral thermal therapy has been validated in vitro for full gland treatment in human prostate geometries.",
keywords = "dualfrequency, MRT feedback control, Prostate cancer, transurethral ultrasound therapy",
author = "N'Djin, {W. A.} and M. Burtnyk and X. Patel and M. Bronskill and R. Chopra",
year = "2012",
doi = "10.1063/1.4757346",
language = "English (US)",
isbn = "9780735410930",
volume = "1481",
pages = "265--270",
booktitle = "AIP Conference Proceedings",

}

TY - GEN

T1 - MRI-guided transurethral ultrasound therapy enables full prostate gland coagulation

T2 - Investigations in gel phantoms

AU - N'Djin, W. A.

AU - Burtnyk, M.

AU - Patel, X.

AU - Bronskill, M.

AU - Chopra, R.

PY - 2012

Y1 - 2012

N2 - MRI-guided transurethral ultrasound therapy has previously been evaluated in human volunteers by treating a prostate subvolume, prior to radical prostatectomy. Extension of this technique to full clinical use requires validation of the technique for coagulating a volume of tissue equivalent to the entire gland. This in-vitro study evaluates approaches for treating the whole prostate gland by comparing various treatment strategies. An 8-element ultrasound therapy system was evaluated in gel phantoms using 6 human prostate profiles segmented from MR clinical images (average volume: 36 cm3). Real-time MR-thermometry feedback was performed over nine slices covering the entire prostate. Decisions on acoustic power, frequency, and device rotation rate were made based on prostate target radii and temperature maps updated every 7s. Low and high power treatment approaches (10, 20 W/cm2) were tested as well as single-and dual-frequency strategies (8.1, 4.6/14.4 MHz). Decreasing frequency to 4.6 MHz enabled treating 97% of the gland on average. A 20/10 W/cm2 dual-frequency 4.6/14.4 MHz treatment was the most efficient configuration in achieving full human prostate treatments. Treatments were performed more quickly (<30min) with enhanced treatment safety close to the base and apex. Transurethral thermal therapy has been validated in vitro for full gland treatment in human prostate geometries.

AB - MRI-guided transurethral ultrasound therapy has previously been evaluated in human volunteers by treating a prostate subvolume, prior to radical prostatectomy. Extension of this technique to full clinical use requires validation of the technique for coagulating a volume of tissue equivalent to the entire gland. This in-vitro study evaluates approaches for treating the whole prostate gland by comparing various treatment strategies. An 8-element ultrasound therapy system was evaluated in gel phantoms using 6 human prostate profiles segmented from MR clinical images (average volume: 36 cm3). Real-time MR-thermometry feedback was performed over nine slices covering the entire prostate. Decisions on acoustic power, frequency, and device rotation rate were made based on prostate target radii and temperature maps updated every 7s. Low and high power treatment approaches (10, 20 W/cm2) were tested as well as single-and dual-frequency strategies (8.1, 4.6/14.4 MHz). Decreasing frequency to 4.6 MHz enabled treating 97% of the gland on average. A 20/10 W/cm2 dual-frequency 4.6/14.4 MHz treatment was the most efficient configuration in achieving full human prostate treatments. Treatments were performed more quickly (<30min) with enhanced treatment safety close to the base and apex. Transurethral thermal therapy has been validated in vitro for full gland treatment in human prostate geometries.

KW - dualfrequency

KW - MRT feedback control

KW - Prostate cancer

KW - transurethral ultrasound therapy

UR - http://www.scopus.com/inward/record.url?scp=84873112024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873112024&partnerID=8YFLogxK

U2 - 10.1063/1.4757346

DO - 10.1063/1.4757346

M3 - Conference contribution

AN - SCOPUS:84873112024

SN - 9780735410930

VL - 1481

SP - 265

EP - 270

BT - AIP Conference Proceedings

ER -